FDA NDC Directory · JSON-LD · Markdown

Rolvedon

NDC 76961-101 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameeflapegrastim-xnst
Labeler / ManufacturerSpectrum Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA761148
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsEFLAPEGRASTIM (13.2 mg/.6mL)
Marketing started20221018
Marketing ended20270831
Package count1

External sources

Source: openFDA. Public-domain (CC0).